NEWS
 FDA approves first drug for Alexander diseaseThe FDA has approved Zanvastro, the first drug that directly targets Alexander disease, a rare neurological disorder. The drug stabilized motor function and showed promising results in clinical trials after decades of research. This is a news summary compiled for the İyi Giden Şeyler newsletter — not the original article. The original article is at sciencedaily.com. Read the original article English (automatic translation) |